Abstract
Understanding the pathobiological processes of cancer metastasis is fundamental to the development of successful cancer therapies. The process of metastasis involves a series of sequential events in which malignant cells are released from the primary tumor and reach distant sites where they proliferate to form new tumor foci. Metastasis begins with the local invasion of the surrounding host tissue by cells from the primary tumor. Tumors that grow in the major body cavities can shed cells which seed the mucosal and/or serosal surfaces of other organs and develop into secondary growths. The more common route of tumor spread involves invasion and penetration of tumor cells into blood vessels and/or the lymphatic system [1–4]. Release of tumor emboli is accelerated by intermittent changes in venous pressure, by turbulent blood flow, and by movement or manipulation of the neoplasms during routine examination, biopsy or surgery [1–5].
Research sponsored by the National Cancer Institute, DHHS, under Contract No. N01-CO-75380 with Litton Bionetics, Inc. The contents of this publications do not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Zeidman I: Metastasis: A review of recent advances, Cancer Res 17: 157–162, 1957.
Fisher B, Fisher ER: The interrelationship of hematogenous and lymphatic tumor cell dissemination. Surg Gynecol Obstet 122: 791–798, 1966.
Fisher ER, Fisher B: Recent observations on concepts of metastasis. Arch Pathol 83:321– 324, 1977.
del Regato JA: Pathways of mestastatic spread of malignant tumors. Semin Oncol 4:33– 38, 1977.
Hoover HC Jr, Ketcham AS: Effect of fine-needle biopsy, incisional biopsy, and palpation on experimental metastasis formation. Surg Forum 27: 110–112, 1976.
Fidler IJ: Metastasis: Quantitative analysis of distribution and fate of tumor emboli labeled with 125I-5-iodo-2’-deoxyuridine. J Natl Cancer Inst 45: 773–782, 1970.
Butler TP, Gullino PM: Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res 35: 512–517, 1975.
Kinsey DL: An experimental study of preferential metastasis. Cancer 13: 674–676, 1960.
Sugarbaker EV, Cohen AM, Ketcham, AS: Do metastases metastasize? Ann Surg 174: 161–166, 1971.
Hart IR, Fidler IJ: Role of organ selectivity in the determination of metastatic patterns of the B16 melanoma. Cancer Res 40: 2281–2287, 1980.
Poste G, Nicolson GL: Modification of the arrest of poorly metastatic tumor cells in the microcirculation after treatment with plasma membrane vesicles from highly metastatic cells. Proc Natl Acad Sci USA 77: 399–403, 1980.
Folkman J: Tumor angiogenesis. Adv Cancer Res 19: 331 — 358, 1974.
Auerbach T, Kubai L, Sidky Y: Angiogenesis induction by tumors, embryonic tissues and lymphocytes. Cancer Res 36: 3435–3440, 1976.
Eastment CT, Sirbasku DA: Human platelet lysate contains growth factor activities for established cell lines derived from various tissues of several species. In Vitro 16:694–701, 1980.
Fidler IJ: Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 38: 2651–2660, 1978.
Fidler IJ: General considerations for studies of experimental cancer metastasis. In: Methods in Cancer Research, Bush H, (ed), New York, Academic Press, 1978, p 399–439.
Poste G, Fidler IJ: The pathogenesis of cancer metastasis. Nature 283: 139–146, 1980.
Rygaard J, Povlsen CO: Heterotransplantation of human malignant tumor to nude mice. Acta Pathol Microbiol Scand, [A] 77: 758–760, 1969.
Kindred B: Nude mice in immunobiology. Prog Allergy 26: 137–238, 1979.
Fogh J, Giovanella BC (eds): The Nude Mouse in Experimental and Clinical Research, New York, Academic Press, 1978.
Nomura T, Ohsawa N, Tamaoki N, Fujiwara K (eds): Proceedings of the Second International Workshop on Nude Mice. Tokyo, University of Tokyo Press, 1977.
Povlsen CO, Fialkow PJ, Klein E, Klein G, Rygaard J, Wiener F: Growth and antigenic properties of a biopsy–derived Burkitt’s lymphoma in thymusless (nude) mice. Int J Cancer 11: 30–39, 1973.
Giovanella BC, Stehlin JS, Williams LJ Jr: Heterotransplantation of human malignant tumors in ‘nude’ thymusless mice. II. Malignant tumors induced by injection of cell cultures derived from human solid tumors. J Natl Cancer Inst 52: 921–927, 1974.
Povlsen CO, Rygaard J: Heterotransplantation of adenocarcinomas of the colon and rectum in the mouse mutant nude. A study of nine consecutive transplantations. Acta Pathol Microbiol Scand [A] 79: 159–169, 1971.
Shimosato Y, Kameya T, Nagai K, Hirohaski S, Koide T, Hayashi H, Normura T: Transplantation of human tumors in nude mice. J Natl Cancer Inst 56: 1251–1260, 1976.
Kuga N, Yoshida K, Seido T, Oboshi S, Koide T, Shimosato Y, Nomura T: Heterotransplantation of cultured human cancer cells and human cancer tissues into nude mice. Gann 66: 547–560, 1975.
Outzen HC, Custer RP: Growth of human normal and neoplastic mammary tissues in the cleared mammary fat pad of the nude mouse. J Natl Cancer Inst 55: 1461–1463, 1975.
Reid LC, Shin SI: Transplantation of heterologous endocrine tumor cells in nude mice. In: The nude mouse in experimental and clinical research, Fogh J, Giovanella B (eds). New York, Academic Press Inc, 1978, p 313–351.
Kameya T, Shimosato Y, Hayashi H, Tsumuraya T: Growth and differentiation of hormone producing human tumors in nude mice. In: Proceeding of the second national workshop on nude mice, Nomura T, Ohsawa N, Tamaoki N, Fujiware K (eds), Tokyo, University of Tokyo, 1977, p 405–412.
Epstein AL, Herman MM, Kim H, Dorfman RF, Kaplan HS: Biology of the human malignant lymphomas III. Intracranial heterotransplantation in the nude, athymic mouse. Cancer 37: 2158–2176, 1976.
Giovanella B Nilsson K, Zech L, Yim O, Klein G, Stehlin JS: Growth of diploid Epstein Barr virus carrying human lymphoblastoid cell lines heterotransplanted into nude mice under immunologically priviledged conditions. Int J Cancer 24: 103–113, 1979.
Schaadt M, Kirchner H, Fonatsch C, Diehl V: Intracranial heterotransplantation of human hematopoietic cells in nude mice. Int J Cancer 23: 751–761, 1979.
Sebesteny A, Taylor-Papadimitriu J, Ceriani R, Millis R, Schmitt C, Trevan D: Primary human breast carcinomas transplantable in the nude mouse. J Natl Cancer Inst 63:1331– 1333, 1979.
Rae-Venter B, Reid LM: Growth of human breast carcinomas in nude mice and subsequent establishment in tissue culture. Cancer Res 40: 95–100, 1980.
Sordat B, Merenda C, Carrel S: Invasive growth and dissemination of human solid tumors and malignant cell lines grafted subcutaneously to newborn nude mice, Nomura T, Ohsawa N, Tamaoki N, Fujiwara K (eds), Tokyo, University of Tokyo Press, 1977, p 313–326.
Povlsen CO: Heterotransplantation of human malignant melanomas to the mouse mutant nude. Acta Pathol Microbiol Scand [A] 84: 9–16, 1976.
Fodstad O, Aass N, Pihl A: Response to chemotherapy of human malignant melanoma xenografts in athymic, nude mice. Int J Cancer 25: 453–458, 1980.
Fogh J, Fogh JM, Orfeo T: One hundred and twenty–seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59: 221–226, 1977.
Giovanella BC, Yim SO, Morgan AC, Stehlin JS, Williams LJ: Metastases of human melanomas transplanted in ‘nude’ mice. J Natl Cancer Inst 50: 1051–1053, 1973.
Rygaard J: Immunobiology of the mouse mutant’ nudeActa Pathol Microbiol Scand [A] 77: 761–762, 1969.
Stiles CD, Desmond W, Chuman LM, Sata G, Saier MH: Growth control of heterologous tissue culture cells in the congenitally athymic nude mouse. Cancer Res 36: 1353–1360, 1976.
Stiles CD, Desmond W, Chuman LM, Sata G, Saier MH, Jr.: Relationship of cell growth behavior in vitro to tumorigenicity in athymic nude mice. Cancer Res 36: 3300–3305, 1976.
Reid LM, Holland J, Jones C, Wolf B, Sato G: Some of the variables affecting the success of transplantation of human tumors into the athymic nude mouse. In: Proceedings of the symposium on the use of athymic (nude) mice in cancer research, Houchens DP, Ovejera AA (eds). New York, Gustav Fischer Verlag, 1978, p 107–121.
Kameya T, Shimosato Y, Tumuraya M, Ohsawa N, Nomura T: Human gastric choriocarcinoma serially transplanted in nude mice. J Natl Cancer Inst 56: 325–329, 1976.
Kyriazis A, DiPersio L, Michael JG, Pesce AJ: Influence of the mouse hepatitis virus (MHV) infection on the growth of human tumors in the athymic mouse. Int J Cancer 23: 402–409, 1979.
Miwa M, Hirohashi S, Shimosato Y, Mukojima T, Ohkura H, Sakura H, Kawachi T, Sugimura T: Coproduction of carcinoembryonic antigen and a-fetoprotein in transplantable human colon cancer in nude mice. In: Proceedings of the second international workshop on nude mice. Nomura T, Ohsawa N, Tamaoki N, Fujiwara K (eds), Tokyo, University of Tokyo Press, 1977, p 435–441.
Kanzaki T, Hashimoto K, Bath DW: Heterotransplantation of human malignant melanoma cell lines in athymic nude mice. J Natl Cancer Inst 62: 1151–1158, 1979.
Fogh J, Hajdu SI: The nude mouse as a diagnostic tool in human tumor cell research. J Cell Biol 67: 117–122, 1975.
Tomphins MB, Rama Rao GV, Tomphins WAF: Increased tumorigenicity and resistance to antibody lysis of human colon tumor cells xenografted in congenitally athymic mice. Cancer Res 39: 2160–2165, 1979.
Price PJ, Arnstein P, Suk WA, Vernon ML, Huebner RJ: Type ‘C’ RNA viruses of the NIH ‘nude’ mouse. J Natl Cancer Instt 55: 1231–1232, 1975.
Manning JK, Reed ND, Jutila JW: Antibody response to Escherichia coli lipopolysaccharide and type III pneumococcal polysaccharide by congenitally thymusless (nude) mice. J Immunol 108: 1470–1476, 1972.
Martin WJ, Martin SE: Naturally occurring cytotoxic anti-tumor antibodies in sera of congenitally athymic (nude) mice. Nature 249: 564–565, 1974.
Meltzer MS: Tumoricidal responses in vitro of peritoneal macrophages from conventionally housed and germ–free nude mice. Cell Immunol 22: 176–181, 1976.
Johnson WJ, Balish E: Macrophage function in germ-free, athymic (nu/nu), and conventional-flora (nu/+) mice. J Reticuloendothel Soc 28: 55–66, 1980.
Herberman RB, Ninn ME, Laurin Dh: Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 16: 216–229, 1975.
Gershwin ME, Ikeda RM, Erickson K Owens R: Enhancement of heterotransplanted human tumor graft survival in nude mice treated with antilymphocytic serum and in congenitally athymic–asplenic (lasat) mice. J Natl Cancer Inst 61: 245–248, 1978.
Lozzio BB, Machado EA, Lair SV, Lozzlo CB: Reproducible metastatic growth of K–562 human myeologenous leukemia cells in nude mice. J Natl Cancer Inst 63: 295–298, 1980.
Ohsugi Y, Gershwin ME, Owens RB, Nelson–Rees WA: Tumorigenicity of human malignant lymphoblasts: Comparative study with unmanipulated nude mice, antilymphocyte serum–treated nude mice, and x–irradiated nude mice. J Natl Cancer Inst 65: 715–718, 1980.
Watanabe S, Shimosato Y, Kuroki M, Sato Y, Nakajima T: Transplantability of human lymphoid cell line, lymphoma, and leukemia in splenectomized and/or irradiated nude mice. Cancer Res 40: 2588–2595, 1980.
Bonmassar E, Campanile F, Houchens D, Crino L, Goldin A: Impaired growth of a radiation-induced lymphoma in intact or lethally irradiated allogeneic athymic (nude) mice. Transplantation 20: 343–346, 1975.
Minato N, Bloom BR, Jones C, Holland J, Reid LM: Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice. J Exp Med 149: 1117–1133, 1979.
Ozello L, Sordat B, Merenda C, Carrel S, Hulimann J, Mach JP: Transplantation of a human mammary carcinoma cell line (BT 20) into nude mice. J Natl Cancer Inst. 52: 1669–1672, 1974.
Giovanella BC, Yim SO, Stehlin JS, Williams LJ: Development of invasive tumors in the 4nude’ mouse after injection of cultured human melanoma cells. J Natl Cancer Inst 18: 1531–1533, 1972.
Sharkey FE, Fogh J: Metastasis of human tumors in athymic nude mice. Int J Cancer 24: 733–738, 1979.
Zamecnik PC, Long JC: Growth of cultured cells from patients with Hodgkin’s disease and transplantation into nude mice. Proc Natl Acad Sci USA 74: 754–758, 1977.
Hata J, Ueyama Y, Tamaoki N, Furukawa T, Morita K: Human neuroblastoma serially transplanted in nude mice and metastases. Cancer 42: 468–473, 1978.
Kyriazis AP, DiPersio L, Michael GJ, Pesce AJ, Stinnett JD: Growth patterns and metastatic behavior of human tumors growing in athymic mice. Cancer Res 38: 3186–3190, 1978.
Takahashi S, Konishi Y, Nakatani K, Inui S, Kojima K, Shiratori T: Conversion of a poorly differentiated human adenocarcinoma to ascites form with invasion and metastasis in nude mice: Brief Communication. J Natl Cancer Inst 60: 925–929, 1978.
Prehn RT, Lappe M: An immunostimulation theory of tumor development. Transplant Rev 7: 26–51, 1971.
Fidler IJ, Gersten DM, Hart IR: The biology of cancer invasion and metastasis. Adv Cancer Res 28: 149–250, 1978.
Fidler IJ, Caines S, Dolan Z: Survival of hematogenously disseminated allogeneic tumor cells in athymic nude mice. Transplantation 22: 208–212, 1976.
Skov CB, Holland JM, Perkins EH: Development of fewer tumor colonies in lungs of athymic nude mice after intravenous injection of tumor cells. J Natl Cancer Inst 56: 193–195, 1976.
Lozzio BB, Lozzio CB, Machado EA: Human myelogenous (Ph’ +) leukemia cell line: Transplantation into athymic mice. J Natl Cancer Inst 56: 627–629, 1978.
Liotta LA, Kleinerman J, Saidel GM: Quantitative relationships of intravascular tumor cells, tumor vessels and pulmonary metastases following tumor implantation. Cancer Res 34: 997–1004, 1974.
Liotta LA, Kleinerman J, Saidel GM: The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res 36: 889–894, 1976.
Fidler IJ: The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur J Cancer 9: 223–227, 1973.
Hanna N, Fidler IJ: The role of natural killer cells in the destruction of circulating tumor emboli. J Natl Cancer Inst 65: 801–809, 1980.
Hanna N: Expression of metastatic potential of tumor cells in young nude mice is correlated with low levels of natural killer cell–mediated cytotoxicity. Int J Cancer 26: 675–680, 1980.
Riccardi C, Puccetti P, Santoni A, Herberman RB: Rapid in vivo assay of mouse natural killer cell activity. J Natl Cancer Inst 63: 1041–1045, 1979.
Talmadge JE, Meyers KM, Prieur DJ, Starkey JR: Role of NK cells in tumor growth and metastasis in beige mice. Nature 284: 622–624, 1980.
Hanna N, Fidler IJ: Expression of metastatic potential of allogenic and xenogeneic in young nude mice. Cancer Res 41: 438–444, 1981.
Kripke ML, Gruys E, Fidler IJ: Metastatic heterogeneity of cells from an ultraviolet light– induced murine fibrosarcoma of recent origin. Cancer Res 38: 2962–2967, 1978.
Willis RA: The spread of tumors in the human body. London, Butterworth, 1972.
Prehn RT: Analysis of antigenic heterogeneity within individual 3-methylcholanthrene-induced mouse sarcomas. J Natl Cancer Inst 45: 1039–1045, 1970.
Biorklund A, Hakansson L, Stenstam B, Trope C, Akerman M: Heterogeneity of non-Hodgkin’s lymphomas as regards sensitivity to cytostatic drugs. An in vitro study. Eur J Cancer 16: 647–654, 1980.
Hakansson L, Trope C: On the presence within tumors of clones that differ in sensitivity to cytostatic drugs. Acta Pathol Microbiol Scand [A] 82: 35–40, 1974.
Heppner GH, Dexter DL, DeNucci T, Miller FR, Calabresi P: Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor. Cancer Res 38: 3758–3763, 1978.
Henderson JS, Rous P: The plating of tumor components on the subcutaneous expanses of young mice. Findings with benign and malignant epidermal growths and with mammary carcinomas. J Exp Med 115: 1211–1230, 1962.
Trope C: Different susceptibilities of tumor cell subpopulations to cytotoxic agents. In: Design of Models for Testing Cancer Therapeutic Agents, Fidler IJ, White RJ (eds), New York, Van Nostrand, in press.
Kerbel RS: Implications of immunological heterogeneity of tumors. Nature 280: 358–360, 1979.
Kripke ML, Gruys E, Fidler IJ: Metastatic heterogeneity of cells from an ultraviolet light-induced murine fibrosarcoma of recent origin. Cancer Res 38: 2962–2967, 1978.
Fidler IJ, Kripke ML: Metastasis results from preexisting variant cells within a malignant tumor. Science 197: 893–895, 1977.
Briles EB, Kornfeld S: Isolation and metastatic properties of detachment variants of B16 melanoma cells. J Natl Cancer Inst 60: 1217–1222, 1978.
Fidler IJ, Gersten DM, Budmen MB: Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity. Cancer Res 36: 3160–3165, 1976.
Tao TW, Burger MM: Nonmetastasizing variants selected from metastasizing melanoma cells. Nature 270: 437–438, 1977.
Fidler IJ: Selection of successive tumor lines for metastasis. Nature 242: 148–149, 1973.
Suzuki N, Withers HR, Koehler MW: Heterogeneity and variability of artificial lung colony-forming ability among clones from mouse fibrosarcoma. J Natl Cancer Inst 60:179– 183, 1978.
Kerbel RS, Twiddy RR, Robertson DM: Induction of a tumor with greatly increased metastatic growth potential by injection of cells from a low-metastatic H-2 heterozygous tumor cell line into an H–2 incompatible parental strain. Int J Cancer 22: 583–594, 1978.
Brunson KW, Nicolson GL: Selection and biologic properties of malignant variants of a murine lymphosarcoma. JNCI 61: 1499–1503, 1978.
Fogel M, Gorelik E, Segal S, Feldman M: Differences in cell surface antigens of tumor metastases and those of the local tumor. JNCI 62: 585–588, 1979.
Killion JJ, Kollmorgen GM: Isolation of immunogenic tumor cells by cell-affinity chromatography. Nature 259: 673–676, 1976.
Schirrmacher V, Shantz G, Glauer K, Komitowsky D, Zimmerman HP, Lohmann-Matthes ML: Tumor metastases and cell–mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo. Int J Cancer 23: 233–244, 1979.
Tao TW, Matter A, Vogel K, Burger MM: Liver–colonizing melanoma cells selected from B16 melanoma. Int J Cancer 23: 854–857, 1979.
Brunson KW, Beattie G, Nicolson GL: Selection and altered properties of brain-colonising metastatic melanoma. Nature 272: 543–545, 1978.
Raz A, Hart IR: Murine melanoma: A model for intracranial metastasis. Br J Cancer 42: 331–341, 1980.
Lotan R: Different susceptibilities of human melanoma and breast carcinoma cell lines to retinoic acid-induced growth inhibition. Cancer Res 39: 1014–1019, 1979.
Fugmann RA, Anderson JC, Stolfi RL, Martin DS: Comparison of adjuvant chemotherapeutic activity against primary and metastatic spontaneous murine tumors. Cancer Res 37: 496–500, 1977.
Schabel FM Jr: Concepts for systemic treatment of micrometastases. Cancer 35: 15–24, 1975.
Trope C, Hakansson L, Dencker H: Heterogeneity of human adenocarcinomas of the colon and the stomach as regards sensitivity to cytostatic drugs. Neoplasma 22: 423–430, 1975.
Trope C: Different sensitivity to cytostatic drugs of primary tumor and metastasis of the Lewis carcinoma. Neoplasma 22: 171–180, 1975.
Hanna N, Burton RC: Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastasis in vivo. J Immunol 127: 1754–1758, 1981.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Martinus Nijhoff Publishers, Boston
About this chapter
Cite this chapter
Hanna, N., Pollack, V.A., Fidler, I.J. (1983). The Use of Young Nude Mice to Study Metastasis of Human Neoplasms. In: Humphrey, G.B., Grindey, G.B., Dehner, L.P., Acton, R.T., Pysher, T.J. (eds) Adrenal and Endocrine Tumors in Children. Cancer Treatment and Research, vol 17. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3891-8_1
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3891-8_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3893-2
Online ISBN: 978-1-4613-3891-8
eBook Packages: Springer Book Archive